Taselisib
| Molecular formula | C24H28N8O2 |
| Molecular weight | 460.53 |
| CAS NO. | 1282512-48-4 |
| Description | API: Taselisib (development code: GDC-0032) is a former cancer drug candidate that was in development by Roche. It is a small molecule phosphoinositide 3-kinase inhibitor targeting the PI3K isoform p110α (PIK3CA). |
